Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Eliminating the Public Health Problem of Hepatitis B and C in the United States. Phase One Report
Type
Physical Book
Publisher
Author
Year
2016
Pages
186
Format
Paperback
Dimensions
22.90 x 15.20 x 2.50 cm
ISBN13
9780309437998

Eliminating the Public Health Problem of Hepatitis B and C in the United States. Phase One Report

Board On Population Health And Public Health Practice;Gillian J. Buckley;Brian L. Strom;Health And Medicine Division;Engineering, And Medicine National Academies Of Sciences;Committee On A National Strategy For The Elimination Of Hepatitis B And C (Author) · National Academies Press · Paperback

Eliminating the Public Health Problem of Hepatitis B and C in the United States. Phase One Report - Board on Population Health and Public Health Practice;Gillian J. Buckley;Brian L. Strom;Health and Medicine Division;Engineering, and Medicine National Academies of Sciences;Committee on a National Strategy for the Elimination of Hepatitis B and C

New Book Imported to New Zealand
Delivery: 13 Aug - 25 Aug Shipping: 12 to 16 business days.
NZ$ 141.84
Import costs and 15% GST included in the price ✅
NZ$ 141.84

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Eliminating the Public Health Problem of Hepatitis B and C in the United States. Phase One Report"

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report. Table of ContentsFront MatterSummary1 Introduction2 The Elimination of Hepatitis B3 The Elimination of Hepatitis C4 ConclusionAppendix A: Committee Meeting 1 AgendaAppendix B: Committee Meeting 2 AgendaAppendix C: Committee BiographiesAppendix D: Glossary

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews